Etanidazole
![]() | |
Names | |
---|---|
IUPAC name
N-(2-Hydroxyethyl)-2-(2-nitro-1H-imidazol-1-yl)acetamide | |
Identifiers | |
22668-01-5 ![]() | |
ChEMBL | ChEMBL47405 ![]() |
ChemSpider | 3161 ![]() |
| |
Jmol-3D images | Image |
PubChem | 3276 |
| |
Properties | |
Molecular formula |
C7H10N4O4 |
Molar mass | 214.18 g·mol−1 |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
![]() ![]() ![]() | |
Infobox references | |
Etanidazole is a nitroimidazole drug used for its radiosensitizing properties. Administration of etanidazole results in a decrease of glutathione concentration and inhibits glutathione S-transferase.[1] The result is that tissues become more sensitive to the ionizing radiation used in cancer treatment.
See also
- EF5, a related nitroimidazole
- Misonidazole
References
- ↑ Definition of etanidazole, National Cancer Institute Drug Dictionary.